Calò, L.A.; Ravarotto, V.; Bertoldi, G.; Pagnin, E.; Rossi, B.; Rigato, M.; Davis, P.A.; Proietti, R.
Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients. J. Clin. Med. 2020, 9, 165.
https://doi.org/10.3390/jcm9010165
AMA Style
Calò LA, Ravarotto V, Bertoldi G, Pagnin E, Rossi B, Rigato M, Davis PA, Proietti R.
Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients. Journal of Clinical Medicine. 2020; 9(1):165.
https://doi.org/10.3390/jcm9010165
Chicago/Turabian Style
Calò, Lorenzo A., Verdiana Ravarotto, Giovanni Bertoldi, Elisa Pagnin, Barbara Rossi, Matteo Rigato, Paul A. Davis, and Riccardo Proietti.
2020. "Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients" Journal of Clinical Medicine 9, no. 1: 165.
https://doi.org/10.3390/jcm9010165
APA Style
Calò, L. A., Ravarotto, V., Bertoldi, G., Pagnin, E., Rossi, B., Rigato, M., Davis, P. A., & Proietti, R.
(2020). Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients. Journal of Clinical Medicine, 9(1), 165.
https://doi.org/10.3390/jcm9010165